1. Glucksberg H, Buckner CD, Fefer A, DeMarsh Q, Copleman D, Dobrow RB, Huff J, Kjobech C, Hill AS, Dittmann W, Neimann PE, Cheever MA, Einstein AB Jr, Thomas ED (1975) Combination chemotherapy for acute nonlymphoblastic leukemia in adults. Cancer Chemother Rep 59: 1131–1137
2. Preisler HD, Rustum Y, Henderson ES, Bjornsson S, Creaven PJ, Higby DJ, Freemann A, Gailani S, Naeher C (1979) Treatment of acute nonlymphocytic leukemia: use of anthracyclin-cytosine arabinoside induction therapy and comparison of two maintenance regimens. Blood 53: 455–464
3. Büchner T, Urbanitz D, Hiddemann W, Rühl H, Ludwig WD, Fischer J, Aul HC, Vaupel HA, Kuse R, Zeile G, Nowrousian MR, König HJ, Walter M, Wendt FC, Sodomann H, Hossfeld DK, Paleske von A, Löffler H, Gassmann W, Hellriegel K-P, Fülle HH, Lunscken CH, Emmerich B, Pralle H, Pees HW, Pfeundschuh M, Bartels H, Poeppen K-M, Schwerdtfeger R, Donhuijsen-Ant R, Mainzer K, Bonfert B, Köppler H, Zurborn K-H, Ranft K, Thiel E, Heinecke A (1985) Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML). Two multicenter studies of the German AML Cooperative Group. J Clin Oncol 3: 1583–1589
4. Gale RP, Foon KA (1987) Therapy of acute myelogenous leukemia. Sem Hematology 24: 40–54
5. Willemze R, Zwaan FE, Colpin G, Keuning JJ (1982) High dose cytosine arabinoside in the management of refractory acute leukemia. Scand J Haematol 29: 141